trial · primary record
4D-150 IVT (3E10 vg/eye)
Macular Neovascularization Secondary to Age-Related Macular Degeneration
| Phase | Phase 3 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 480 |
| Primary completion | 2028-06 |
| Primary endpoint | Mean change from baseline in BCVA ETDRS letter score at Week 52 |
| Registry ID | NCT06864988 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:33:14.498Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06864988
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.